Literature DB >> 28366534

SMA mutations in SMN Tudor and C-terminal domains destabilize the protein.

Toru Takarada1, Mawaddah Ar Rochmah2, Nur Imma Fatimah Harahap2, Masakazu Shinohara2, Toshio Saito3, Kayoko Saito4, Poh San Lai5, Yoshihiro Bouike6, Yasuhiro Takeshima7, Hiroyuki Awano8, Ichiro Morioka8, Kazumoto Iijima8, Hisahide Nishio9, Atsuko Takeuchi1.   

Abstract

BACKGROUND AND
PURPOSE: Most spinal muscular atrophy (SMA) patients are homozygous for survival of motor neuron 1 gene (SMN1) deletion. However, some SMA patients carry an intragenic SMN1 mutation. Such patients provide a clue to understanding the function of the SMN protein and the role of each domain of the protein. We previously identified mutations in the Tudor domain and C-terminal region of the SMN protein in three Japanese SMA patients. To clarify the effect of these mutations on protein stability, we conducted expression assays of SMN with mutated domains. PATIENTS AND METHODS: Patients A and B carried a mutation in SMN1 exon 3, which encodes a Tudor domain, c.275G>C (p.Trp92Ser). Patient C carried a mutation in SMN1 exon 6, which encodes a YG-box; c.819_820insT (p.Thr274Tyrfs). We constructed plasmid expression vectors containing wild-type and mutant SMN1 cDNAs. After transfection of HeLa cells with the expression plasmids, RNA and protein were isolated and analyzed by reverse-transcription PCR and western blot analysis.
RESULTS: The abundance of wild-type and mutant SMN1 transcripts in HeLa cells was almost the same. However, western blot analysis showed lower levels of mutant SMN proteins compared with wild-type SMN. In mutant SMN proteins, it is noteworthy that the level of the p.Thr274Tyrfs mutant was much reduced compared with that of the p.Trp92Ser mutant.
CONCLUSIONS: SMN mutations may affect the stability and levels of the protein.
Copyright © 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-terminal region; SMN mutation; SMN stability; Tudor domain; YG box

Mesh:

Substances:

Year:  2017        PMID: 28366534     DOI: 10.1016/j.braindev.2017.03.002

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Temperature-sensitive spinal muscular atrophy-causing point mutations lead to SMN instability, locomotor defects and premature lethality in Drosophila.

Authors:  Amanda C Raimer; Suhana S Singh; Maina R Edula; Tamara Paris-Davila; Vasudha Vandadi; Ashlyn M Spring; A Gregory Matera
Journal:  Dis Model Mech       Date:  2020-05-22       Impact factor: 5.758

Review 2.  Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.

Authors:  Marianna A Maretina; Galina Y Zheleznyakova; Kristina M Lanko; Anna A Egorova; Vladislav S Baranov; Anton V Kiselev
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

3.  Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy.

Authors:  Emma Tabe Eko Niba; Hisahide Nishio; Yogik Onky Silvana Wijaya; Mawaddah Ar Rochmah; Toru Takarada; Atsuko Takeuchi; Tomokazu Kimizu; Kentaro Okamoto; Toshio Saito; Hiroyuki Awano; Yasuhiro Takeshima; Masakazu Shinohara
Journal:  Genes (Basel)       Date:  2022-01-24       Impact factor: 4.096

4.  How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?

Authors:  Wei Li
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.